ORAMED PHARMACEUTICALS INC. Balance Sheet
ORMP|10 years of annual SEC 10-K data (FY2016-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 10 fiscal years. All figures from audited SEC 10-K filings.
ORAMED PHARMACEUTICALS INC. had $231M in total assets and $145M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $45.9M | - | $9.1M | - | $19.3M | $3.3M | $5.0M | $3.9M | $3.2M | $1.8M |
| Current Assets | $133.3M | $143.2M | $162.6M | $157.1M | $95.3M | $40.5M | $33.3M | $31.0M | $20.3M | $31.2M |
| PP&E (Net) | $586.0K | $698.0K | $873.0K | $815.0K | $397.0K | $99.0K | $24.0K | $17.0K | $18.0K | $16.0K |
| Total Assets | $230.9M | $155.3M | $220.6M | $161.6M | $128.0M | $44.6M | $34.7M | $47.4M | $38.7M | $42.8M |
| Current Liabilities | $19.1M | $5.7M | $53.2M | $5.7M | $6.7M | $4.5M | $5.3M | $4.6M | $5.2M | $3.6M |
| Shareholders' Equity | $145.3M | $146.3M | $163.8M | $151.8M | $115.8M | $19.4M | $31.1M | $26.2M | $24.8M | $20.8M |